Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
NEW YORK, Aug. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019http://www.reportlinker.com/p0946319/Addison's-Disease-Primary-or-Chronic-Adrenal-Insufficiency-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Summary Addison Addison Addison Addison Scope Addison- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Addison's Disease Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Addison's Disease Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Addison's Disease Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Addison's Disease Therapeutics market
Reasons to buy- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Addison's Disease Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Addison's Disease Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global Addison's Disease Therapeutics market landscape? – Identify, understand and capitalize.
Table of Contents1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Addison's Disease Therapeutics - Introduction 6
2.1 Disease Overview 6
2.1.1 Types of Adrenal Insufficiency 6
2.2 Epidemiology 8
2.3 Etiology 8
2.3.1 Autoimmune Disorders 8
2.3.2 Tuberculosis 8
2.3.3 Other Causes 8
2.4 Pathophysiology 9
2.5 Symptoms and Clinical Signs 9
2.6 Commonly Used Diagnostic Tests 10
2.7 Treatment and Management Options for Addison's Disease 10
2.7.1 Types of Glucocorticoid Drugs and their Doses 10
2.8 GlobalData Pipeline Report Guidance 11
3 Addison's Disease Therapeutics - Market Characterization 12
3.1 Addison's Disease Therapeutics Market Size (2006-2011) - Global 12
3.2 Addison's Disease Therapeutics Market Forecast (2011-2019) - Global 13
3.3 Addison's Disease Therapeutics Market Size (2006-2011) - The US 14
3.4 Addison's Disease Therapeutics Market Forecast (2011-2019) - The US 15
3.5 Addison's Disease Therapeutics Market Size (2006-2011) - France 16
3.6 Addison's Disease Therapeutics Market Forecast (2011-2019) - France 17
3.7 Addison's Disease Therapeutics Market Size (2006-2011) - Germany 18
3.8 Addison's Disease Therapeutics Market Forecast (2011-2019) - Germany 19
3.9 Addison's Disease Therapeutics Market Size (2006-2011) - Italy 20
3.10 Addison's Disease Therapeutics Market Forecast (2011-2019) - Italy 21
3.11 Addison's Disease Therapeutics Market Size (2006-2011) - Spain 22
3.12 Addison's Disease Therapeutics Market Forecast (2011-2019) - Spain 23
3.13 Addison's Disease Therapeutics Market Size (2006-2011) - The UK 24
3.14 Addison's Disease Therapeutics Market Forecast (2011-2019) - The UK 25
3.15 Addison's Disease Therapeutics Market Size (2006-2011) - Japan 26
3.16 Addison's Disease Therapeutics Market Forecast (2011-2019) - Japan 27
3.17 Drivers and Barriers for the Addison's Disease Therapeutics Market 28
3.17.1 Drivers for the Addison's Disease Therapeutics Market 28
3.17.2 Barriers to the Addison's Disease Therapeutics Market 28
3.18 Opportunity and Unmet Need Analysis 29
3.19 Key Takeaway 30
4 Addison's Disease Therapeutics - Competitive Assessment 31
4.1 Overview 31
4.2 Strategic Competitor Assessment 31
4.3 Product Profiles for the Marketed Products in the Addison's Disease Therapeutics Market 32
4.3.1 Glucocorticoid Replacement Therapy 32
4.3.2 Mineralocorticoid Replacement Therapy 33
4.4 Key Takeaway 33
5 Addison's Disease Therapeutics - Pipeline Assessment 34
5.1 Overview 34
5.2 Strategic Pipeline Assessment 34
5.2.1 Addison's Disease Therapeutics - Phase I Clinical Pipeline 34
5.3 Technology Trends Analytic Framework 34
5.4 Recently Approved Pipeline Product 35
5.4.1 Plenadren (hydrocortisone) 35
5.5 Key Takeaway 36
6 Addison's Disease Therapeutics - Clinical Trials Mapping 37
6.1 Clinical Trials by Region and Country 37
6.2 Clinical Trials by Phase 38
6.3 Clinical Trials by Trial Status 38
6.4 Clinical Trials Mapping by Sponsors 39
7 Addison's Disease Therapeutics - Strategic Assessment 40
7.1 Key Events Impacting the Future Market 40
7.2 Addison's Disease Therapeutics - Implications for Future Market Competition 41
8 Addison's Disease Therapeutics Market - Future Players 42
8.1 Introduction 42
8.2 Company Profiles 42
8.2.1 DuoCort Pharma AB 42
8.2.2 ViroPharma 43
9 Addison's Disease Therapeutics - Licensing and Partnership Deals 44
10 Addison's Disease Therapeutics - Appendix 45
10.1 Market Definitions 45
10.2 Acronyms 45
10.3 Research Methodology 45
10.3.1 Coverage 45
10.3.2 Secondary Research 46
10.3.3 Forecasting 46
10.3.4 Primary Research 49
10.3.5 Expert Panel Validation 49
10.4 Contact Us 49
10.5 Disclaimer 49
10.6 Bibliography 50
List of TablesTable 1: Addison's Disease Prevalence in Seven Major Markets 8
Table 2: Signs and Symptoms of Adrenal Insufficiency 9
Table 3: Most Commonly Glucocorticoid Drugs and Doses 10
Table 4: Addison's Disease Therapeutics Market, Global, Revenue ($m), 2006-2011 12
Table 5: Addison's Disease Therapeutics Market, Global, Forecast ($m), 2011-2019 13
Table 6: Addison's Disease Therapeutics Market, The US, Revenue ($m), 2006-2011 14
Table 7: Addison's Disease Therapeutics Market, The US, Forecasts ($m), 2011-2019 15
Table 8: Addison's Disease Therapeutics Market, France, Revenue ($m), 2006-2011 16
Table 9: Addison's Disease Therapeutics Market, France, Forecasts ($m), 2011-2019 17
Table 10: Addison's Disease Therapeutics Market, Germany, Revenue ($m), 2006-2011 18
Table 11: Addison's Disease Therapeutics Market, Germany, Forecasts ($m), 2011-2019 19
Table 12: Addison's Disease Therapeutics Market, Italy, Revenue ($m), 2006-2011 20
Table 13: Addison's Disease Therapeutics Market, Italy, Forecasts ($m), 2011-2019 21
Table 14: Addison's Disease Therapeutics Market, Spain, Revenue ($m), 2006-2011 22
Table 15: Addison's Disease Therapeutics Market, Spain, Forecasts ($m), 2011-2019 23
Table 16: Addison's Disease Therapeutics Market, The UK, Revenue ($m), 2006-2011 24
Table 17: Addison's Disease Therapeutics Market, The UK, Forecasts ($m), 2011-2019 25
Table 18: Addison's Disease Therapeutics Market, Japan, Revenue ($m), 2006-2011 26
Table 19: Addison's Disease Therapeutics Market, Japan, Forecasts ($m), 2011-2019 27
Table 20: Addison's Disease Therapeutics-Phase I Pipeline, 2011 34
Table 21: Addison's Disease Therapeutics - Clinical Trials by Country, 2011 37
Table 22: Addison's Disease Therapeutics - Clinical Trials by Phase, 2011 38
Table 23: Addison's Disease Therapeutics - Clinical Trials by Status, 2011 38
Table 24: Addison's Disease Therapeutics - Overall Sponsors, 2011 39
Table 25: Addison's Disease Therapeutics Market - Clinical Pipeline by Company, 2011 42
Table 26: Addison's Disease - Global, Deals, 2011 44
List of FiguresFigure 1: Adrenal Hormones Regulation 7
Figure 2: Addison's Disease Therapeutics Market, Global, Revenue ($m), 2006-2011 12
Figure 3: Addison's Disease Therapeutics Market, Global, Forecast ($m), 2011-2019 13
Figure 4: Addison's Disease Therapeutics Market, The US, Forecast ($m), 2006-2011 14
Figure 5: Addison's Disease Therapeutics Market, The US, Forecasts ($m), 2011-2019 15
Figure 6: Addison's Disease Therapeutics Market, France, Revenue ($m), 2006-2011 16
Figure 7: Addison's Disease Therapeutics Market, France, Forecast ($m), 2011-2019 17
Figure 8: Addison's Disease Therapeutics Market, Germany, Revenue ($m), 2006-2011 18
Figure 9: Addison's Disease Therapeutics Market, Germany, Forecast ($m), 2011-2019 19
Figure 10: Addison's Disease Therapeutics Market, Italy, Revenue ($m), 2006-2011 20
Figure 11: Addison's Disease Therapeutics Market, Italy, Forecast ($m), 2011-2019 21
Figure 12: Addison's Disease Therapeutics Market, Spain, Revenue ($m), 2006-2011 22
Figure 13: Addison's Disease Therapeutics Market, Spain, Forecast ($m), 2011-2019 23
Figure 14: Addison's Disease Therapeutics Market, The UK, Revenue ($m), 2006-2011 24
Figure 15: Addison's Disease Therapeutics Market, The UK, Forecast ($m), 2011-2019 25
Figure 16: Addison's Disease Therapeutics Market, Japan, Revenue ($m), 2006-2011 26
Figure 17: Addison's Disease Therapeutics Market, Japan, Forecasts ($m), 2011-2019 27
Figure 18: Opportunity and Unmet Need in the Addison's Disease Therapeutics Market 30
Figure 19: Addison's Disease Therapeutics - Strategic Competitor Assessment, 2011 31
Figure 20: Addison's Disease Therapeutics - Technology Trends Analytics Framework, 2011 34
Figure 21: Addison's Disease Therapeutics - Technology Trends Analytics Framework - Description, 2011 35
Figure 22: Addison's Disease Therapeutics - Clinical Trials by Country, 2011 37
Figure 23: Addison's Disease Therapeutics - Clinical Trials by Phase, 2011 38
Figure 24: Addison's Disease Therapeutics - Overall Sponsors, 2011 39
Figure 25: Addison's Disease Therapeutics Market, Drivers and Barriers, 2011 40
Figure 26: Implications for Future Market Competition in the Addison's Disease Therapeutics Market, 2011 41
Figure 27: GlobalData Market Forecasting Model 48
Companies MentionedViroPharma
To order this report:Therapy Industry: Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019More
Market Research ReportCheck our
Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article